Treatment depends on classification on histology and the clinical status of patient.
Acute T-Cell Medicated Rejection (Acute Cellular rejection)
1. Type IA or IB acute cellular rejection (no evidence of vascular or antibody-mediated rejection)
- Methylprednisolone 500mg IV daily for 3 doses
- Consider ATG if steroid resistant cellular rejection
2. Type IIA, IIB ORĀ vascular rejection
- Methylprednisolone 500mg IV daily for 3 doses
- ATG treatment dosing (see protocol below)